MoveDMD Trial: Catabasis Provides Update (February 2017) The Catabasis team spoke to our community on February 2, 2017 to discuss what they learned from this latest trial and what comes next in the MoveDMD program. Research & Clinical Trial Webinars,Webinars 8 years ago You may also like 43:40 Webinar: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy 9 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 51:42 Webinar: Overview of DUVYZAT and Access Resources (September 2024) 9 months ago Research & Clinical Trial Webinars,Webinars 1:04:54 Webinar: Advocating for A Successful School Year (September 2024) 9 months ago Care Webinars,Webinars 1:01:24 Webinar: PPMD Advocacy – Raising Our Voices in 2024 and Beyond [Sep 2024] 9 months ago Webinars 1:00:59 Webinar: Advancing DYNE-251 – An Investigational Medicine for Duchenne to Deliver for Patients 10 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:05:32 Webinar: Edgewise Therapeutics – Clinical Trials in Becker Muscular Dystrophy 10 months ago Research & Clinical Trial Webinars,Webinars edgewise 58:10 Webinar: Community Progress in Duchenne Newborn Screening 1 year ago Webinars feature,newborn screening 1:01:30 Webinar: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat) 1 year ago Research & Clinical Trial Webinars,Webinars duvyzat,feature,givinostat,itf therapeutics «12345…26»Page 3 of 26